Skip to main content

Nicardipine for the Treatment of Neonatal Hypertension During Extracorporeal Membrane Oxygenation

Pediatric Cardiology volume 40, pages 1041–1045 (2019)Cite this article

Abstract

Extracorporeal membrane oxygenation (ECMO) is one of the primary reasons systemic hypertension is experienced in hospitalized neonates. Commonly used antihypertensive agents have resulted in significant adverse effects in neonatal and pediatric populations. Nicardipine is a desirable option because of its rapid and titratable antihypertensive properties and low incidence of adverse effects. However, data for use in neonatal ECMO are limited. We conducted a retrospective review of patients less than 44 weeks post-menstrual age who received a nicardipine infusion for first-line treatment of systemic hypertension while on ECMO at our institution between 2010 and 2016. Systolic (SBP), diastolic (DBP), and mean arterial (MAP) blood pressures were evaluated for 48-h after nicardipine initiation. Eight neonates received a nicardipine infusion while on ECMO during the study period. Nicardipine was initiated at a mean dose of 0.52 ( ± 0.22) mcg/kg/min and titrated to a maximum dose of 1.1 ( ± 0.85) mcg/kg/min. The median duration of nicardipine use was 51 (range 4–227) hours. Significant decreases in SBP, DBP, and MAP occurred within one hour of initiation of nicardipine and were sustained through the majority of the 48-h evaluation period. No patients experienced hypotension. Prospective studies are warranted to evaluate the optimal dose, safety, and efficacy of nicardipine in neonates who require ECMO.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Blowey DL, Duda PJ, Stokes P, Hall M (2011) Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens 5:478–483

    Article  PubMed  Google Scholar 

  2. Batisky DL (2014) Neonatal hypertension. Clin Perinatol 41:529–542

    Article  PubMed  Google Scholar 

  3. Boedy RF, Goldberg AK, Howell CG Jr, Hulse E, Edwards EG, Kanto WP Jr (1990) Incidence of hypertension in infants on extracorporeal membrane oxygenation. J Pediatr Surg 25:258–261

    Article  CAS  PubMed  Google Scholar 

  4. Becker JA, Short BL, Martin GR (1998) Cardiovascular complications adversely affect survival during extracorporeal membrane oxygenation. Crit Care Med 26:1582–1586

    Article  CAS  PubMed  Google Scholar 

  5. Sell LL, Cullen ML, Lerner GR, Whittlesey GC, Shanley CJ, Klein MD (1987) Hypertension during extracorporeal membrane oxygenation: cause, effect, and management. Surgery 102:724–730

    CAS  PubMed  Google Scholar 

  6. Heggen JA, Fortenberry JD, Tanner AJ, Reid CA, Mizzell DW, Pettignano R (2004) Systemic hypertension associated with venovenous extracorporeal membrane oxygenation for pediatric respiratory failure. J Pediatr Surg 39:1626–1631

    Article  PubMed  Google Scholar 

  7. Ku LC, Zimmerman K, Benjamin DK, Clark RH, Hornik CP, Smith PB (2017) Safety of enalapril in infants admitted to the neonatal intensive care unit. Pediatr Cardiol 38:155–161

    Article  PubMed  Google Scholar 

  8. Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810

    Article  CAS  PubMed  Google Scholar 

  9. Perlman JM, Volpe JJ (1989) Neurologic complications of captopril treatment of neonatal hypertension. Pediatrics 83:47–52

    CAS  PubMed  Google Scholar 

  10. Moffett BS, Price JF (2008) Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients. Ann Pharmacother 42:1600–1604

    Article  CAS  PubMed  Google Scholar 

  11. Hammer GB, Lewandowski A, Drover DR, Rosen DA, Cohen C, Anand R et al (2015) Safety and efficacy of sodium nitroprusside during prolonged infusion in pediatric patients. Pediatr Crit Care Med 16:397–403

    Article  PubMed  Google Scholar 

  12. Radford D (1983) Side effects of verapamil in infants. Arch Dis Child 58:465–466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Garland JS, Berens RJ, Losek JD, Wilson AD (1985) An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil. Pediatr Emerg Care 1:198–200

    Article  CAS  PubMed  Google Scholar 

  14. Kirk CR, Gibb JL, Thomas R, Radley-Smith R, Qureshi SA (1987) Cardiovascular collapse after verapamil in supraventricular tachycardia. Arch Dis Child 62:1265–1266

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Flynn JT, Tullus K (2009) Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 24:1101–1112

    Article  PubMed  Google Scholar 

  16. Treluyer JM, Hubert P, Jouvet P, Couderc S, Cloup M (1993) Intravenous nicardipine in hypertensive children. Eur J Pediatr 152:712–714

    Article  CAS  PubMed  Google Scholar 

  17. Gouyon JB, Geneste B, Semama DS, Françoise M, Germain JF (1997) Intravenous nicardipine in hypertensive preterm infants. Arch Dis Child Fetal Neonatal Ed 76:F126–F127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Milou C, Debuche-Benouachkou V, Semama DS, Germain JF, Gouyon JB (2000) Intravenous nicardipine as a first-line antihypertensive drug in neonates. Intensive Care Med 26:956–958

    Article  CAS  PubMed  Google Scholar 

  19. Fanaroff JM, Fanaroff AA (2006) Blood pressure disorders in the neonate: hypotension and hypertension. Semin Fetal Neonatal Med 11:174–181

    Article  PubMed  Google Scholar 

  20. Malesker MA, Hilleman DE (2012) Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients. J Crit Care 27:528.e7–14

    Article  CAS  Google Scholar 

  21. Halpern NA, Goldberg M, Neely C, Sladen RN, Goldberg JS, Floyd J et al (1992) Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med 20:1637–1643

    Article  CAS  PubMed  Google Scholar 

  22. Bebawy JF, Houston CC, Kosky JL, Badri AM, Hemmer LB, Moreland NC et al (2015) Nicardipine is superior to esmolol for the management of postcraniotomy emergence hypertension: a randomized open-label study. Anesth Analg 120:186–192

    Article  CAS  PubMed  Google Scholar 

  23. Vecht RJ, Swanson KT, Nicolaides EP, Lennox SC, Gibson DG (1989) Comparison of intravenous nicardipine and nitroglycerin to control systemic hypertension after coronary artery bypass grafting. Am J Cardiol 64:19H–21H

    Article  CAS  PubMed  Google Scholar 

  24. Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38–43

    Article  CAS  PubMed  Google Scholar 

  25. McBride BF, White CM, Campbell M, Frey BM (2003) Nicardipine to control neonatal hypertension during extracorporeal membrane oxygen support. Ann Pharmacother 37:667–670

    Article  PubMed  Google Scholar 

  26. Tobias JD, Pietsch JB, Lynch A (1996) Nicardipine to control mean arterial pressure during extracorporeal membrane oxygenation. Paediatr Anaesth 6:57–60

    Article  CAS  PubMed  Google Scholar 

  27. Levene MI, Gibson NA, Fenton AC, Papathoma E, Barnett D (1990) The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants. Dev Med Child Neurol 32:567–574

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Pharmacy, St. Louis Children’s Hospital One Children’s Place, St. Louis, MO, 63110, USA

    Caren J. Liviskie, Brandy N. Zeller & Christopher C. McPherson

  2. Southern Illinois University in Edwardsville School of Pharmacy, 200 University Park Dr, Edwardsville, IL, 62025, USA

    Kathryn M. DeAvilla

  3. Department of Pediatrics, Washington University School of Medicine, 660 South Euclid Ave, St. Louis, MO, 63110, USA

    Tasnim Najaf & Christopher C. McPherson

Authors
  1. Caren J. Liviskie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathryn M. DeAvilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brandy N. Zeller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tasnim Najaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christopher C. McPherson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caren J. Liviskie.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

For this type of study, formal consent is not required. Approval for this study was obtained from the Washington University in St. Louis Institutional Review Board.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liviskie, C.J., DeAvilla, K.M., Zeller, B.N. et al. Nicardipine for the Treatment of Neonatal Hypertension During Extracorporeal Membrane Oxygenation. Pediatr Cardiol 40, 1041–1045 (2019). https://doi.org/10.1007/s00246-019-02113-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-019-02113-3

Keywords

  • Antihypertensive agents
  • Extracorporeal membrane oxygenation
  • Hypertension
  • Neonate
  • Nicardipine